Funding Round Overview

Terray Therapeutics announced a Series B round on October 1, 2025 totaling $120,000,000 led by ARCH Venture Partners. Terray Therapeutics raised $120 million Series B with Nvidia participating. $120M Series B with NVenture.

Deal Highlights

• Capital involved: $120,000,000.
• Round: Series B.
• Investors: ARCH Venture Partners, NVenture (Nvidia), EcoR1 Capital.

Company and Sector Context

Terray Therapeutics builds in the healthcare ai sector, one of the most active areas in AI investment today. Based in United States, the company is part of a global wave of startups scaling AI into production across regulated and enterprise environments.

How the Capital Helps

Disclosed details include $120M Series B with NVenture. In healthcare ai, speed to market and access to high-quality talent often determine category leadership.

Competitive Landscape

Funding activity in healthcare ai continues to intensify as incumbents and startups race to ship reliable AI systems. This round signals ongoing investor confidence in differentiated technology and defensible distribution.

Looking Ahead

This funding positions Terray Therapeutics for continued growth in the healthcare ai landscape. As AI adoption accelerates across industries, deals like this signal where capital and strategic attention are moving next.